These include Programmed Death-1 (PD-1), another inhibitory receptor on T cells, and its ligands, PD-L1 and PD-L2, which can be expressed by tumor cells and other cells in the tumor microenvironment. This evidence concerns the gene PDCD1 and neoplasm.